Effective chronic care management for human and animal health.
We develop solutions for sustainably providing measurable health information, enabling frequent patient/provider interactions. Our technology enhances adherence-to-care-plans, improving outcomes and containing healthcare costs.
Connecting clinicians and patients.
Our diabetes management solutions shift the current patient self-care model to a more effective and efficient active patient management model by connecting the clinicians, patients, testing supplies, and health data together through our groundbreaking technology
Multi-market glucose monitoring solution.
We adapted our diabetes management solution to serve the desperate need in animal health for better glucose testing and monitoring by offering the GluCurve Pet CGM which combines both the industry first CGM for pets with the first of its kind patient management portal.
ALR Technologies Announces Completion of Pivotal Non-Inferiority Study on the GluCurve Pet CGM
ALR Technologies Inc., the diabetes management company, today announced successful results from the conclusion of the non-inferiority study conducted on the GluCurve Pet CGM which was previously announced on February 10, 2022 and February 28, 2022.
ALR Technologies Announces Successful Preliminary Results for the GluCurve Pet CGM Non-Inferiority Study
ALR Technologies Inc., the diabetes management company, today announced preliminary results from the Non-Inferiority Study currently being conducted on the GluCurve Pet CGM (GluCurve)
Why invest in ALRT?
We believe diabetes is among the top drivers of healthcare costs, morbidity, and mortality because of two reasons, Clinical Inertia- failure to advance therapy on a timely basis, and patient self-management. We have worked to solve these two issues through first of their kind features such as active patient management, patent pending predictive A1C, FDA cleared insulin dose adjustments, non-insulin therapy advancements, direct meter uploads, data processing, remote care, and more!